Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anayatollah Salimi, Hanna Ghobadian & Behzad Sharif Makhmalzadeh. (2021) Dermal pharmacokinetics of rivastigmine-loaded liposomes: an ex vivo–in vivo correlation study. Journal of Liposome Research 31:3, pages 246-254.
Read now
Read now
D. Nagasamy Venkatesh, S. N. Meyyanathan, R. Shanmugam, S. S. Kamatham, J. R. Campos, J. Dias-Ferreira, E. Sanchez-Lopez, J. C. Cardoso, P. Severino & E. B. Souto. (2021) Physicochemical, pharmacokinetic, and pharmacodynamic characterization of isradipine tablets for controlled release. Pharmaceutical Development and Technology 26:1, pages 92-100.
Read now
Read now
Antonio Di Stefano, Antonio Iannitelli, Sara Laserra & Piera Sozio. (2011) Drug delivery strategies for Alzheimer's disease treatment. Expert Opinion on Drug Delivery 8:5, pages 581-603.
Read now
Read now
Ben Seltzer. (2010) Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease. Clinical Interventions in Aging 5, pages 1-6.
Read now
Read now
Articles from other publishers (15)
L. Torras-Claveria, S. Berkov, F. Viladomat & J. Bastida. (2021) QToF exact mass and ESI fragmentation of bioactive Amaryllidaceae alkaloids. South African Journal of Botany 136, pages 81-90.
Crossref
Crossref
Ross Dunne & Alistair Burns. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
433
453
.
Katie Malone & Jules C. Hancox. (2020)
QT interval prolongation and
Torsades de Pointes
with donepezil, rivastigmine and galantamine
. Therapeutic Advances in Drug Safety 11, pages 204209862094241.
Crossref
Crossref
Shweta Sharma. 2020. Sustainable Agriculture Reviews 43. Sustainable Agriculture Reviews 43
131
159
.
Muriel Noetzli & Chin B. Eap. (2013) Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease. Clinical Pharmacokinetics 52:4, pages 225-241.
Crossref
Crossref
José María García-Alberca, José Pablo Lara, Belén Cruz, Victoria Garrido, Esther Gris & Miguel Ángel Barbancho. (2013) Sleep Disturbances in Alzheimer’s Disease Are Associated With Neuropsychiatric Symptoms and Antidementia Treatment. Journal of Nervous & Mental Disease 201:3, pages 251-257.
Crossref
Crossref
Rebecca L. Ashare, Riju Ray, Caryn Lerman & Andrew A. Strasser. (2012) Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study. Drug and Alcohol Dependence 126:1-2, pages 263-267.
Crossref
Crossref
K. Engedal, B. Davis, U. Richarz, J. Han, B. Schäuble & N. Andreasen. (2012) Two galantamine titration regimens in patients switched from donepezil. Acta Neurologica Scandinavica 126:1, pages 37-44.
Crossref
Crossref
Irving H. Gomolin, Candace Smith & Thomas M. Jeitner. (2011) Cholinesterase Inhibitors: Applying Pharmacokinetics to Clinical Decision Making. The American Journal of Geriatric Pharmacotherapy 9:4, pages 259-263.
Crossref
Crossref
Katrien Van Puyvelde & Tony Mets. (2011) Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: A study in a real life population. Geriatrics & Gerontology International 11:3, pages 256-261.
Crossref
Crossref
Jiong Shi & Ben Seltzer. (2011) Galantamine: an update. Neurodegenerative Disease Management 1:3, pages 227-234.
Crossref
Crossref
A. Kurz, M. Farlow & G. Lefèvre. (2009) Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review. International Journal of Clinical Practice 63:5, pages 799-805.
Crossref
Crossref
Nazem Bassil & George T. Grossberg. (2009) Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease. CNS Drugs 23:4, pages 293-307.
Crossref
Crossref
Douglas W. Scharre, Thomas Shiovitz, Young Zhu & Joan Amatniek. (2007) One‐week dose titration of extended release galantamine in patients with Alzheimer's disease. Alzheimer's & Dementia 4:1, pages 30-37.
Crossref
Crossref
Fiona Dunbar, Young Zhu & H. Robert Brashear. (2006) Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study. Clinical Therapeutics 28:3, pages 365-372.
Crossref
Crossref